GB9220571D0 - Quinazoline derivatives - Google Patents

Quinazoline derivatives

Info

Publication number
GB9220571D0
GB9220571D0 GB929220571A GB9220571A GB9220571D0 GB 9220571 D0 GB9220571 D0 GB 9220571D0 GB 929220571 A GB929220571 A GB 929220571A GB 9220571 A GB9220571 A GB 9220571A GB 9220571 D0 GB9220571 D0 GB 9220571D0
Authority
GB
United Kingdom
Prior art keywords
quinazoline derivatives
quinazoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929220571A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Imperial Chemical Industries Ltd
Original Assignee
Institute of Cancer Research
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research, Imperial Chemical Industries Ltd filed Critical Institute of Cancer Research
Priority to GB929220571A priority Critical patent/GB9220571D0/en
Publication of GB9220571D0 publication Critical patent/GB9220571D0/en
Priority to ZA936768A priority patent/ZA936768B/en
Priority to IL107028A priority patent/IL107028A0/en
Priority to PCT/GB1993/002015 priority patent/WO1994007869A1/en
Priority to AU48297/93A priority patent/AU4829793A/en
Priority to GB9320077A priority patent/GB2271111A/en
Priority to MX9306034A priority patent/MX9306034A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65128—Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
GB929220571A 1992-09-30 1992-09-30 Quinazoline derivatives Pending GB9220571D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB929220571A GB9220571D0 (en) 1992-09-30 1992-09-30 Quinazoline derivatives
ZA936768A ZA936768B (en) 1992-09-30 1993-09-14 Quinazoline derivatives
IL107028A IL107028A0 (en) 1992-09-30 1993-09-19 Quinazoline derivatives
PCT/GB1993/002015 WO1994007869A1 (en) 1992-09-30 1993-09-28 Quinazoline derivatives
AU48297/93A AU4829793A (en) 1992-09-30 1993-09-28 Quinazoline derivatives
GB9320077A GB2271111A (en) 1992-09-30 1993-09-29 Quinazoline derivatives
MX9306034A MX9306034A (en) 1992-09-30 1993-09-29 QUINAZOLINE DERIVATIVES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929220571A GB9220571D0 (en) 1992-09-30 1992-09-30 Quinazoline derivatives

Publications (1)

Publication Number Publication Date
GB9220571D0 true GB9220571D0 (en) 1992-11-11

Family

ID=10722718

Family Applications (2)

Application Number Title Priority Date Filing Date
GB929220571A Pending GB9220571D0 (en) 1992-09-30 1992-09-30 Quinazoline derivatives
GB9320077A Withdrawn GB2271111A (en) 1992-09-30 1993-09-29 Quinazoline derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9320077A Withdrawn GB2271111A (en) 1992-09-30 1993-09-29 Quinazoline derivatives

Country Status (5)

Country Link
AU (1) AU4829793A (en)
GB (2) GB9220571D0 (en)
IL (1) IL107028A0 (en)
WO (1) WO1994007869A1 (en)
ZA (1) ZA936768B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320113D0 (en) * 1993-09-29 1993-11-17 Zeneca Ltd Tricyclic derivatives
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
EP0981343B1 (en) 1997-05-14 2005-09-14 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
US6753428B2 (en) 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
US8349850B2 (en) 2006-03-28 2013-01-08 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2139320A4 (en) 2007-03-26 2010-09-08 Salutria Pharmaceuticals Llc Methods and compositions of derivatives of probucol for the treatment of diabetes
EP2697206B1 (en) 2011-04-10 2019-04-03 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
WO2021198191A1 (en) 2020-03-30 2021-10-07 Enyo Pharma Quinazolinone derivatives and uses thereof for treating a cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
IL98167A0 (en) * 1990-05-30 1992-06-21 Ici Plc Anti-tumour quinazoline derivatives,processes for their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
GB2271111A (en) 1994-04-06
ZA936768B (en) 1994-03-30
AU4829793A (en) 1994-04-26
GB9320077D0 (en) 1993-11-17
IL107028A0 (en) 1993-12-28
WO1994007869A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
ZA951458B (en) Quinazoline derivatives
PL307812A1 (en) Substituted thiazolydinone derivatives
ZA89623B (en) Quinazoline derivatives
GB9305306D0 (en) Pyrrolo-pyridazione derivatives
HU9301955D0 (en) Benzophenone-hydrazone derivatives
IL107749A0 (en) Phthalazinone derivatives
GB9320077D0 (en) Quinazoline derivatives
ZA931876B (en) 2-Oxoquinoline derivatives
HU9501693D0 (en) Benzazepinone derivatives
ZA932639B (en) Propenoyl-imidazole derivatives
HU9301616D0 (en) New thio-semicarbazone derivatives
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
ZA931516B (en) Substituted phenylquinazoline derivatives
EP0565961A3 (en) Ethyl-triazolyl derivatives
HU9302058D0 (en) Thia-diazinone derivatives
GB9223244D0 (en) Phenylpyrazine derivatives
GB9223735D0 (en) Quinazoline derivatives
GB9225765D0 (en) Quinazoline derivatives
GB9213572D0 (en) Quinazoline derivatives
GB9213570D0 (en) Quinazoline derivatives
GB9201095D0 (en) Quinazoline derivatives
GB9310248D0 (en) Quinazoline derivatives
GB9122316D0 (en) Quinazoline derivatives
HU9202008D0 (en) New 4-methyl-2-imidazolinone derivatives